Scientists are excitedly focused on retatrutide, a innovative drug developed by Eli Lilly, as a potential step in physique loss . Distinct from many earlier approaches, retatrutide is a twin-action compound targeting simultaneously GLP-1 and GIP, substances that impact hunger and blood glucose r… Read More